GETTING TIME BACK

Our PDC technology targets specific receptors with atomic precision. Using custom-designed peptides with optimized binding properties, we deliver therapeutic payloads directly to cells in the precise physiological locations of disease.

How Receptor Targeting Works

• Specificity: Our peptides are designed to bind only to specific receptors in the exact locations where treatment is needed
• Affinity: Modular and predictive binding affinity ensures enhanced targeting precision
• Selectivity: Minimal binding to off-target receptors reduces side effects
• Customization: Our platform can target virtually any receptor with custom-designed peptides

Using computational design and screening, we identify peptide sequences that bind targets with unprecedented precision. This approach enables targeting of previously "undruggable" disease pathways.

Our PDC technology targets specific receptors on cell surfaces in the precise physiological locations of disease. The peptide-directed particles enter cells through receptor-mediated endocytosis, delivering therapeutic payloads to their intended targets. This approach improves efficacy while reducing off-target effects.

Delivery Process Steps

1. Targeting: PDCs bind specifically to receptors in the precise locations where treatment is needed
2. Internalization: Receptor-mediated endocytosis draws PDCs into the cell
3. Endosomal Escape: Specialized mechanisms release the therapeutic payload into the cytoplasm or nucleus
4. Therapeutic Action: Payloads reach their intracellular targets for maximum efficacy

This multi-step process ensures therapeutics not only reach the right cells but also maintain their activity once inside. Our technology is payload-agnostic and can deliver mRNA, DNA, CRISPR, and other gene editing technologies.